Abstract:Therapy of thyroid cancers is based on the removal of the primary disease by surgery, replacement of the hormonal deficiencies and subsequent therapy of the recurrent and metastatic disease. The metabolic characteristics of many thyroid tumours mean that radionuclide techniques have been used in the identification of sites of tumour and their subsequent therapy.Differentiated thyroid cancers, papillary, follicular and mixed papillary follicular, are treated by surgery — usually a total or subtotal thyroidectomy Postoperatively, patients have thyroxine as a replacement therapy and to suppress thyroid-stimulating hormone production. Radioiodine therapy is often given to ablate the thyroid remnant. This allows (a) adequate follow-up of patients using thyroglobulin measurements and assessment scans as necessary, and (b) further therapy with radioiodine for metastatic disease.Patients with a short effective half-life of radioiodide may require higher activities or pharmacological methods of prolonging the retention half-times of iodine. The use of chemotherapy in this group of tumours is limited and at best provides palliation. The overall prognosis is good for differentiated thyroid cancer; papillary carcinomas have an 80 to 90% 10-year survival, whereas follicular tumours are associated with a 65 to 75% 10-year survival.Medullary carcinomas may be sporadic or familial, and some of the latter form part of a multiple endocrine neoplasia syndrome (MEN). Primary treatment is surgery, and total thyroidectomy is usually recommended since tumours are often multifocal. The use of radiolabelled metaiodobenzylguanidine (MIBG) and 111In octreotide as potential therapeutic agents has been explored and may be potentially useful in palliative care. Chemotherapy is of limited benefit. The 10-year survival for medullary carcinomas is 60 to 70%.Anaplastic tumours of the thyroid are usually aggressive, with a high mortality. Treatment is palliative by surgical debulking; some patients may benefit from local radiotherapy or occasionally chemotherapy.The use of therapeutic doses of radionuclides is well tolerated, although it may be associated with a variety of mostly transient adverse effects, including gastritis, thyroiditis and sialadenitis. Therapy with high activities of radioiodine require radiation protection precautions. Despite retreatment with radioiodine there appear to be no long term effects on the fertility of patients, and healthy children are born to women receiving this treatment.131I remains perhaps the most specific cancer therapy available today and has few adverse effects. It is difficult to see any marked improvement being developed for differentiated thyroid cancer, with the possible exception of targeted gene therapy.

Thyroxine Suppressive Therapy in Patients with Nodular Thyroid Disease

Thyroxine suppressive therapy of benign solitary thyroid nodules: A prospective randomized study

Pharmacotherapy for thyroid nodules A systematic review and meta-analysis

CHANGING CONCEPTS IN THE DIAGNOSIS AND MANAGEMENT OF THYROID NODULES

Long-Term Effects of 0.1 mg Recombinant-Human-Thyrotropin-Stimulated Fixed-Dose Radioiodine Therapy in Patients with Recurrent Multinodular Goiter after Surgery

The treatment of autonomous functioning thyroid nodules

Ultrasound-Guided Radiofrequency and Microwave Ablation for the Management of Patients With Benign Thyroid Nodules Systematic Review and Meta-Analysis

Natural History of Benign Solid and Cystic Thyroid Nodules

Analysis of the clinical effects of comprehensive drug treatment for thyroid nodules

Contemporary Thyroid Nodule Evaluation and Management

Thyroid Nodules: Advances in Evaluation and Management

Thyroid nodules: Α guide to assessment, treatment and follow-up

Clinical inertia in thyrotropin suppressive therapy for low-risk differentiated thyroid cancer: A real-world experience at an endocrine center in Bangkok

Is hemithyroidectomy a rational management for benign nodular goitre? A Multicentre Retrospective Single Group Study

Long-term follow-up of treatment outcomes in Graves' disease and toxic nodular disease

Assessing the relative effectiveness of various ultrasound-guided ablation techniques for treating benign thyroid nodules: A systematic review and network meta-analysis

Radiofrequency Ablation for Treatment of Benign Thyroid Nodules

Thyroid nodules: diagnosis and management

Drug Therapy Alternatives in the Treatment of Thyroid Cancer

Administration of thyroxine in treated Graves' disease. Effects on the level of antibodies to thyroid-stimulating hormone receptors and on the risk of recurrence of hyperthyroidism